Bernd R. Seizinger - 11 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Reporting relationship: Director
Issuer ticker: ONCY
Reported as of: 11 Feb 2026
Net transaction value: +$83,454
SEC form: 4
Accepted by SEC: 13 Feb 2026, 07:00:23 UTC
Prior SEC filing: 20 Jan 2026
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirk Look, Attorney-in-Fact

Key filing fact

Bernd R. Seizinger filed Form 4 for ONCOLYTICS BIOTECH INC (ONCY) on 13 Feb 2026.

Key facts

This page summarizes Bernd R. Seizinger's Form 4 filing for ONCOLYTICS BIOTECH INC (ONCY).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Feb 2026, 07:00.

Change

Previous filing in this sequence was filed on 20 Jan 2026.
Current net transaction value: +$83,454.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001789042 Primary reporting owner

Seizinger Bernd R.

Relationship: Director
Address: C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO
Signature: /s/ Kirk Look, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONCY transaction

Common Shares

Purchase

Transaction value: $49,590
Shares: +60,000
Change %: +13%
Price: $0.8265
Shares after: 526,991
Date: 11 Feb 2026
Ownership: Direct

ONCY transaction

Common Shares

Purchase

Transaction value: $33,864
Shares: +40,000
Change %: +7.6%
Price: $0.8466
Shares after: 566,991
Date: 12 Feb 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .